Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Apr;196(1):28-38.
doi: 10.1111/cei.13265. Epub 2019 Feb 27.

Exploring immunomodulation by endocrine changes in Lady Windermere syndrome

Affiliations
Review

Exploring immunomodulation by endocrine changes in Lady Windermere syndrome

M R Holt et al. Clin Exp Immunol. 2019 Apr.

Abstract

Lung disease due to nontuberculous mycobacteria (NTM) occurs with disproportionate frequency in postmenopausal women with a unique phenotype and without clinically apparent predisposing factors. Dubbed 'Lady Windermere syndrome', the phenotype includes low body mass index (BMI), tall stature and higher than normal prevalence of scoliosis, pectus excavatum and mitral valve prolapse. Although the pathomechanism for susceptibility to NTM lung disease in these patients remains uncertain, it is likely to be multi-factorial. A role for the immunomodulatory consequences of oestrogen deficiency and altered adipokine production has been postulated. Altered levels of adipokines and dehydroepiandrosterone have been demonstrated in patients with NTM lung disease. Case reports of NTM lung disease in patients with hypopituitarism support the possibility that altered endocrine function influences disease susceptibility. This paper catalogues the evidence for immunomodulatory consequences of predicted endocrine changes in Lady Windermere syndrome, with emphasis on the immune response to NTM. Collectively, the data warrant further exploration of an endocrine link to disease susceptibility in Lady Windermere syndrome.

Keywords: adipokines; hormones; immune response; nontuberculous mycobacteria; oestrogen.

PubMed Disclaimer

Conflict of interest statement

The authors have no personal, professional or financial conflicts of interest relevant to this paper.

Figures

Figure 1
Figure 1
The immune response to nontuberculous mycobacteria (NTM) and predicted modulation by hormone changes. Macrophages phagocytose NTM and produce tumour necrosis factor (TNF)‐α and interleukin (IL)‐12. TNF‐α activates macrophage functions in an autocrine manner and both hormones stimulate NK cells to produce IFN‐γ. Macrophages and other antigen‐presenting cells produce IL‐12, which facilitates lymphoproliferation and drives polarisation of CD4 cells to the T helper type 1 (Th1) phenotype. Th1 and CD8 cells produce IFN‐γ, which further activates macrophages, establishing a positive feedback loop with IL‐12. Predicted modulation of these processes by hormone changes is indicated by black (inhibitory effect) and red (enhancing effect) connecting lines.

Similar articles

Cited by

References

    1. Gupta RS, Lo B, Son J. Phylogenomics and comparative genomic studies robustly support division of the genus Mycobacterium into an emended genus Mycobacterium and four novel genera. Front Microbiol 2018; 9:67. - PMC - PubMed
    1. Falkinham JO III. Environmental sources of nontuberculous mycobacteria. Clin Chest Med 2015; 36:35–41. - PubMed
    1. Griffith DE, Aksamit T, Brown‐Elliott BA et al An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175:367–416. - PubMed
    1. Prevots DR, Marras TK. Epidemiology of human pulmonary infection with nontuberculous mycobacteria: a review. Clin Chest Med 2015; 36:13–34. - PMC - PubMed
    1. Honda JR, Knight V, Chan ED. Pathogenesis and risk factors for nontuberculous mycobacterial lung disease. Clin Chest Med 2015; 36:1–11. - PubMed